Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

The Common Terminology Criteria for Adverse Events (CTCAE) were developed to document the adverse effects of chemotherapy but are now also used to document immune-related adverse events (irAE). Characterization of irAE by the CTCAE has implications for determining dose-limiting toxicity (DLT) and, c...

Celý popis

Podrobná bibliografia

Vydané v:	JNCI : Journal of the National Cancer Institute Ročník 109; číslo 4
Hlavní autori:	Friedman, Claire F, Clark, Varina, Raikhel, Andrew V, Barz, Tim, Shoushtari, Alexander N, Momtaz, Parisa, Callahan, Margaret K, Wolchok, Jedd D, Chapman, Paul B, Hellmann, Matthew D, Postow, Michael A
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.04.2017
Predmet:	Amylases - blood Antibodies, Monoclonal - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Female Humans Ipilimumab Lipase - blood Male Melanoma - drug therapy Pancreatitis - blood Pancreatitis - chemically induced Retrospective Studies
ISSN:	1460-2105
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!